{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:26:24Z","timestamp":1793834784361,"version":"4.6.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["NCTMH002857; NCTMH002844"],"award-info":[{"award-number":["NCTMH002857; NCTMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857; ZIAMH002844"],"award-info":[{"award-number":["ZIAMH002857; ZIAMH002844"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG00029"],"award-info":[{"award-number":["Z01-AG00029"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite distinct receptor targets, both ketamine and serotonergic psychedelics produce a rapid clinical response and share biological signatures that suggest convergence on common downstream molecular mediators. To identify shared biomarkers of rapid antidepressant response, this study integrated CSF proteomics from healthy volunteers (HVs) who received intravenous ketamine with transcriptomic analyses from induced pluripotent stem cells (iPSCs) derived from participants with treatment-resistant depression (TRD) and HVs; iPSCs were treated with ketamine, its metabolite (2\u2009\n                    <jats:italic>R<\/jats:italic>\n                    ,6\u2009\n                    <jats:italic>R<\/jats:italic>\n                    )-hydroxynorketamine, lysergic acid diethylamide (LSD), or psilocybin. Multimodal clinical characterization (transcriptomics (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200916 TRD; 11 HV), magnetoencephalography (MEG) (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930 TRD; 25 HV), and plasma cytokines (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200939 TRD; 25 HV) were also performed on TRD and HV participants who received a single dose of intravenous ketamine (0.5\u2009mg\/kg) or placebo. Conserved immune pathways were identified across CSF and iPSC neurons with interleukin-15 (IL)-15 and monocyte chemoattractant protein-1 (MCP-1) emerging as key regulatory hubs. Transcriptomically, in whole blood, ketamine responders exhibited decreased IL-15 and elevated B-cell signaling pathways at baseline that were reversed post-treatment. At the protein level, plasma IL-7 levels (primary B-cell driver) correlated with baseline MEG gamma power, reaching brain-wide significance across all participants (main effect p\n                    <jats:sub>FDR<\/jats:sub>\n                    \u2009&lt;\u20090.05). The association was most pronounced in the TRD participants across subcortical regions (diagnosis x IL-7 p\n                    <jats:sub>FDR<\/jats:sub>\n                    \u2009&lt;\u200910\n                    <jats:sup>-14<\/jats:sup>\n                    ). Post-ketamine, the TRD IL-7\u2013gamma relationship inverted, paralleling widespread gamma power reductions throughout default-mode network regions (session x IL-7 p\n                    <jats:sub>clc<\/jats:sub>\n                    \u2009&lt;\u20090.05). In mixed-effects models, cytokine ratios linked to IL-7\/IL-15 signaling predicted antidepressant response (IL-4\/interferon gamma (IFN-\u03b3) p\n                    <jats:sub>FDR<\/jats:sub>\n                    \u2009&lt;\u20090.041) and non-response (MCP-1\/IL-7 p\n                    <jats:sub>FDR<\/jats:sub>\n                    \u2009&lt;\u20090.009), suggesting that rebalancing within the IL-7\/IL-15 axis may contribute to therapeutic efficacy. Clinicaltrials.gov identifier: NCT00088699; NCT02484456.\n                  <\/jats:p>","DOI":"10.1038\/s41380-026-03777-z","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:08:12Z","timestamp":1785244092000},"page":"7251-7263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics"],"prefix":"10.1038","volume":"31","author":[{"given":"Gregory H.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-6172","authenticated-orcid":false,"given":"Jessica R.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-3179","authenticated-orcid":false,"given":"Jenessa N.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-4969","authenticated-orcid":false,"given":"Anton","family":"Schulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-318X","authenticated-orcid":false,"given":"Miranda","family":"Arakelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewurakua A.","family":"Winful","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Yavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Elkahloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline D.","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Greenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-1190","authenticated-orcid":false,"given":"Rodrigo","family":"Machado-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-4130","authenticated-orcid":false,"given":"Christopher M.","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-9451","authenticated-orcid":false,"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1093-1648","authenticated-orcid":false,"given":"Mark D.","family":"Kvarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-305X","authenticated-orcid":false,"given":"Francis J.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3777_CR1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387:1637\u201348.","journal-title":"N Engl J Med"},{"key":"3777_CR2","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1038\/s41380-022-01757-7","volume":"27","author":"RB Price","year":"2022","unstructured":"Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED, et al. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Mol Psychiatry. 2022;27:5096\u2013112.","journal-title":"Mol Psychiatry"},{"key":"3777_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02973-1","volume":"14","author":"Z Shen","year":"2024","unstructured":"Shen Z, Gao D, Lv X, Wang H, Yue W. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients. Transl Psychiatry. 2024;14:248.","journal-title":"Transl Psychiatry"},{"key":"3777_CR4","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1017\/S0033291723001411","volume":"53","author":"P McCrone","year":"2023","unstructured":"McCrone P, Fisher H, Knight C, Harding R, Schlag AK, Nutt DJ, et al. Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model. Psychol Med. 2023;53:7619\u201326.","journal-title":"Psychol Med"},{"key":"3777_CR5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384:1402\u201311.","journal-title":"N Engl J Med"},{"key":"3777_CR6","first-page":"512","volume":"9","author":"B Szigeti","year":"2024","unstructured":"Szigeti B, Heifets BD. Expectancy effects in psychedelic trials. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9:512\u201321.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3777_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","volume":"79","author":"DB Yaden","year":"2022","unstructured":"Yaden DB, Potash JB, Griffiths RR. Preparing for the bursting of the psychedelic hype bubble. JAMA Psychiatry. 2022;79:943\u20134.","journal-title":"JAMA Psychiatry"},{"key":"3777_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nat Rev Neurosci. 2010;11:642\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mp.2015.83","volume":"21","author":"MS Milak","year":"2016","unstructured":"Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, et al. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol Psychiatry. 2016;21:320\u20137.","journal-title":"Mol Psychiatry"},{"key":"3777_CR10","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","volume":"43","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, et al. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018;43:2154\u201360.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","volume":"45","author":"NL Mason","year":"2020","unstructured":"Mason NL, Kuypers KPC, M\u00fcller F, Reckweg J, Tse DHY, Toennes SW, et al. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology. 2020;45:2003\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep46421","volume":"7","author":"MM Schartner","year":"2017","unstructured":"Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Sci Rep. 2017;7:46421.","journal-title":"Sci Rep"},{"key":"3777_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","volume":"277","author":"AL Halberstadt","year":"2015","unstructured":"Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. 2015;277:99\u2013120.","journal-title":"Behav Brain Res"},{"key":"3777_CR14","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170\u201382.","journal-title":"Cell Rep"},{"key":"3777_CR15","doi-asserted-by":"crossref","first-page":"115775","DOI":"10.1016\/j.biopha.2023.115775","volume":"169","author":"F Madrid-Gambin","year":"2023","unstructured":"Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, et al. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. Biomed Pharmacother. 2023;169:115775.","journal-title":"Biomed Pharmacother"},{"key":"3777_CR16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42003-023-05093-6","volume":"6","author":"I Brys","year":"2023","unstructured":"Brys I, Barrientos SA, Ward JE, Wallander J, Petersson P, Halje P. 5-HT2AR and NMDAR psychedelics induce similar hyper-synchronous states in the rat cognitive-limbic cortex-basal ganglia system. Communications Biology. 2023;6:737.","journal-title":"Communications Biology"},{"key":"3777_CR17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5166 patients and 5083 controls. Brain Behav Immun. 2020;87:901\u20139.","journal-title":"Brain Behav Immun"},{"key":"3777_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. 2019;81:24\u201340.","journal-title":"Brain Behav Immun"},{"key":"3777_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.64719\/pb.4425","volume":"52","author":"A Gasparini","year":"2022","unstructured":"Gasparini A, Callegari C, Lucca G, Bellini A, Caselli I, Ielmini M. Inflammatory biomarker and response to antidepressant in major depressive disorder: A systematic review and meta-analysis. Psychopharmacol Bull. 2022;52:36\u201352.","journal-title":"Psychopharmacol Bull"},{"key":"3777_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer CA, Klann E. mTOR signaling: At the crossroads of plasticity, memory, and disease. Trends Neurosci. 2010;33:67.","journal-title":"Trends Neurosci"},{"key":"3777_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","volume":"30","author":"JD Powell","year":"2012","unstructured":"Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune rsponses by mTOR. Annu Rev Immunol. 2012;30:39\u201368.","journal-title":"Annu Rev Immunol"},{"key":"3777_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpsychires.2016.12.002","volume":"87","author":"HM Abelaira","year":"2017","unstructured":"Abelaira HM, R\u00e9us G, Ign\u00e1cio ZM, Dos Santos MAB, de Moura AB, Matos D, et al. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex. J Psychiatr Res. 2017;87:81\u201387.","journal-title":"J Psychiatr Res"},{"key":"3777_CR23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00213-016-4256-3","volume":"233","author":"K Holubova","year":"2016","unstructured":"Holubova K, Kleteckova L, Skurlova M, Ricny J, Stuchlik A, Vales K. Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner. Psychopharmacology (Berl). 2016;233:2077\u201397.","journal-title":"Psychopharmacology (Berl)"},{"key":"3777_CR24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science"},{"key":"3777_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P-f, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91\u201395.","journal-title":"Nature"},{"key":"3777_CR26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.12688\/f1000research.8236.1","volume":"5","author":"S Popp","year":"2016","unstructured":"Popp S, Behl B, Joshi JJ, Lanz TA, Spedding M, Schenker E, et al. In search of the mechanisms of ketamine\u2019s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis. F1000 Research. 2016;5:634.","journal-title":"F1000 Research"},{"key":"3777_CR27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","volume":"45","author":"CG Abdallah","year":"2020","unstructured":"Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, et al. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology. 2020;45:990\u20137.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR28","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105821","volume":"115","author":"KA Pucha","year":"2023","unstructured":"Pucha KA, Ma TC, York W, Kang UJ, Kaufmann H, Kapogiannis D, et al. Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophy. Parkinsonism Relat Disord. 2023;115:105821.","journal-title":"Parkinsonism Relat Disord"},{"key":"3777_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41586-022-05213-y","volume":"609","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Fan Q, Luo X, Lou K, Weiss WA, Shokat KM. Brain-restricted mTOR inhibition with binary pharmacology. Nature. 2022;609:822\u20138.","journal-title":"Nature"},{"key":"3777_CR30","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","volume":"5","author":"TF Cloughesy","year":"2008","unstructured":"Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, et al. Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med. 2008;5:e8.","journal-title":"PLoS Med"},{"key":"3777_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108527","volume":"26","author":"R Moaddel","year":"2023","unstructured":"Moaddel R, Farmer CA, Yavi M, Kadriu B, Zhu M, Fan J, et al. Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion. iScience. 2023;26:108527.","journal-title":"iScience"},{"key":"3777_CR32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2215-0366(23)00183-9","volume":"10","author":"GC Medeiros","year":"2023","unstructured":"Medeiros GC, Matheson M, Demo I, Reid MJ, Matheson S, Twose C, et al. Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies. Lancet Psychiatry. 2023;10:790\u2013800.","journal-title":"Lancet Psychiatry"},{"key":"3777_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mp.2017.241","volume":"23","author":"L Cavalleri","year":"2017","unstructured":"Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF, et al. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Mol Psychiatry. 2017;23:812\u201323.","journal-title":"Mol Psychiatry"},{"key":"3777_CR34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"3777_CR35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bioinformatics\/btaa687","volume":"37","author":"GE Hoffman","year":"2021","unstructured":"Hoffman GE, Roussos P. Dream: powerful differential expression analysis for repeated measures designs. Bioinformatics. 2021;37:192\u2013201.","journal-title":"Bioinformatics"},{"key":"3777_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 2016;17:483.","journal-title":"BMC Bioinformatics"},{"key":"3777_CR37","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u2013D646.","journal-title":"Nucleic Acids Res"},{"key":"3777_CR38","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of bomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"3777_CR39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"3777_CR40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr., Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"key":"3777_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"3777_CR42","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","volume":"35","author":"G Sturm","year":"2019","unstructured":"Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436\u2013i445.","journal-title":"Bioinformatics"},{"key":"3777_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu T, Wang Z, Pe\u2019er D, Danko CG. Cell type and gene expression deconvolution with bayesprism enables bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat Cancer. 2022;3:505\u201317.","journal-title":"Nat Cancer"},{"key":"3777_CR44","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u2013.e3529.","journal-title":"Cell"},{"key":"3777_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biostatistics\/kxp046","volume":"11","author":"MG Kenward","year":"2010","unstructured":"Kenward MG, Roger JH. The use of baseline covariates in crossover studies. Biostatistics. 2010;11:1\u201317.","journal-title":"Biostatistics"},{"key":"3777_CR46","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21105\/joss.02815","volume":"5","author":"MS Ben-Shachar","year":"2020","unstructured":"Ben-Shachar MS, L\u00fcdecke D, Makowski D. effectsize: estimation of effect size indices and standardized parameters. J Open Source Softw. 2020;5:2815.","journal-title":"J Open Source Softw"},{"key":"3777_CR47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/meth.2001.1238","volume":"25","author":"J Vrba","year":"2021","unstructured":"Vrba J, Robinson SE. Signal processing in magnetoencephalography. Methods. 2021;25:249\u201371.","journal-title":"Methods"},{"key":"3777_CR48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162\u201373.","journal-title":"Comput Biomed Res"},{"key":"3777_CR49","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.21105\/joss.03139","volume":"6","author":"D L\u00fcdecke","year":"2021","unstructured":"L\u00fcdecke D, Ben-Shachar MS, Patil I, Waggoner P, Makowski D. performance: An R package for assessment, comparison and testing of statistical models. J Open Source Softw. 2021;6:3139.","journal-title":"J Open Source Softw"},{"key":"3777_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03724-6","volume":"15","author":"JN Johnston","year":"2025","unstructured":"Johnston JN, Yuan P, Kadriu B, Akula N, Quintanilla B, Peng S, et al. Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2\u2009R,6\u2009R)-hydroxynorketamine and reelin: an exploratory study. Transl Psychiatry. 2025;15:524.","journal-title":"Transl Psychiatry"},{"key":"3777_CR51","doi-asserted-by":"crossref","first-page":"557-62","DOI":"10.1136\/rapm-00115550-199924060-00015","volume":"24","author":"MP Yeager","year":"1999","unstructured":"Yeager MP, Lunt P, Arruda J, Whalen K, Rose R, DeLeo JA. Cerebrospinal fluid cytokine levels after surgery with spinal or general anesthesia. Reg Anesth Pain Med. 1999;24:557-62.","journal-title":"Reg Anesth Pain Med"},{"key":"3777_CR52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","volume":"30","author":"CM Coyle","year":"2015","unstructured":"Coyle CM, Laws KR. The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum Psychopharmacol. 2015;30:152\u201363.","journal-title":"Hum Psychopharmacol"},{"key":"3777_CR53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cei.13118","volume":"192","author":"LA Aqrawi","year":"2018","unstructured":"Aqrawi LA, Ivanchenko M, Bj\u00f6rk A, Sep\u00falveda JIR, Imgenberg-Kreuz J, Kvarnstr\u00f6m M, et al. Diminished CXCR5 expression in peripheral blood of patients with Sj\u00f6gren\u2019s syndrome may relate to both genotype and salivary gland homing. Clin Exp Immunol. 2018;192:259\u201370.","journal-title":"Clin Exp Immunol"},{"key":"3777_CR54","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.3390\/ijms26157500","volume":"26","author":"Sza\u0142ach \u0141P","year":"2025","unstructured":"Sza\u0142ach \u0141P, Ciesielska-Figlon K, Daca A, Cuba\u0142a WJ, Lisowska KA. The effect of ketamine on the immune system in patients with treatment-resistant depression. Int J Mol Sci. 2025;26:7500.","journal-title":"Int J Mol Sci"},{"key":"3777_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-025-09755-9","volume":"649","author":"C Yue","year":"2026","unstructured":"Yue C, Wang N, Zhai H, Yuan Z, Cui Y, Quan J, et al. Adenosine signalling drives antidepressant actions of ketamine and ECT. Nature. 2026;649:423\u201331.","journal-title":"Nature"},{"key":"3777_CR56","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41386-020-00949-5","volume":"46","author":"N Akula","year":"2021","unstructured":"Akula N, Marenco S, Johnson K, Feng N, Zhu K, Schulmann A, et al. Deep transcriptome sequencing of subgenual anterior cingulate cortex reveals cross-diagnostic and diagnosis-specific RNA expression changes in major psychiatric disorders. Neuropsychopharmacology. 2021;46:1364\u201372.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783:673\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"3777_CR58","volume":"13","author":"Q Yang","year":"2022","unstructured":"Yang Q, Fu B, Luo D, Wang H, Cao H, Chen X, et al. The multiple bological functions of dipeptidyl peptidase-4 in bone metabolism. Front Endocrinol (Lausanne). 2022;13:856954.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3777_CR59","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4103\/1673-5374.259610","volume":"14","author":"X Morato","year":"2019","unstructured":"Morato X, Cunha RA, Ciruela F. G protein-coupled receptor 37 (GPR37) emerges as an important modulator of adenosinergic transmission in the striatum. Neural Regen Res. 2019;14:1912\u20134.","journal-title":"Neural Regen Res"},{"key":"3777_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-50618-0","volume":"15","author":"BS White","year":"2024","unstructured":"White BS, de Reyni\u00e8s A, Newman AM, Waterfall JJ, Lamb A, Petitprez F, et al. Community assessment of methods to deconvolve cellular composition from bulk gene expression. Nat Commun. 2024;15:1\u201322.","journal-title":"Nat Commun"},{"key":"3777_CR61","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1128\/JVI.77.18.10168-10171.2003","volume":"77","author":"AA Ashkar","year":"2003","unstructured":"Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol. 2003;77:10168\u201371.","journal-title":"J Virol"},{"key":"3777_CR62","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.4049\/jimmunol.1003965","volume":"187","author":"LE Gordy","year":"2011","unstructured":"Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol. 2011;187:6335\u201345.","journal-title":"J Immunol"},{"key":"3777_CR63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965303","volume":"13","author":"C Apert","year":"2022","unstructured":"Apert C, Galindo-Albarr\u00e1n AO, Castan S, Detraves C, Michaud H, McJannett N, et al. IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+Foxp3+ regulatory T lymphocytes. Front Immunol. 2022;13:965303.","journal-title":"Front Immunol"},{"key":"3777_CR64","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1172\/JCI69780","volume":"124","author":"J Wu","year":"2014","unstructured":"Wu J, Yang J, Yang K, Wang H, Gorentla B, Shin J, et al. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J Clin Invest. 2014;124:1685\u201398.","journal-title":"J Clin Invest"},{"key":"3777_CR65","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.1302076","volume":"192","author":"J Wu","year":"2014","unstructured":"Wu J, Shin J, Xie D, Wang H, Gao J, Zhong X-P. Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity. J Immunol. 2014;192:2643\u201350.","journal-title":"J Immunol"},{"key":"3777_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12730","volume":"7","author":"M Yang","year":"2016","unstructured":"Yang M, Chen S, Du J, He J, Wang Y, Li Z, et al. NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation. Nat Commun. 2016;7:12730.","journal-title":"Nat Commun"},{"key":"3777_CR67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/imcb.12248","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Hill BJ, Darko S, Song K, Quigley MF, Asher TE, et al. The peripheral differentiation of human natural killer T cells. Immunol Cell Biol. 2019;97:586\u201396.","journal-title":"Immunol Cell Biol"},{"key":"3777_CR68","volume":"11","author":"Y Fang","year":"2023","unstructured":"Fang Y, Bian C, Li Z, Jin L, Chen C, Miao Y, et al. ScRNA\u2010seq revealed disruption in CD8+ NKG2A+ natural killer T cells in patients after liver transplantation and immunosuppressive therapy. Immun Inflamm Dis. 2023;11:e990.","journal-title":"Immun Inflamm Dis"},{"key":"3777_CR69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2020.00202","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Guan D, Wang S, Chai LYA, Xu S, Lam K-P. Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions. Front Immunol. 2020;11:202.","journal-title":"Front Immunol"},{"key":"3777_CR70","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111516","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar A, Yarosz EL, Andren A, Zhang L, Lyssiotis CA, Chang C-H. NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function. Cell Rep. 2022;41:111516.","journal-title":"Cell Rep"},{"key":"3777_CR71","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.0800489","volume":"182","author":"YK Parrish","year":"2009","unstructured":"Parrish YK, Baez I, Milford T-A, Benitez A, Galloway N, Rogerio JW, et al. IL-7 dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol. 2009;182:4255\u201366.","journal-title":"J Immunol"},{"key":"3777_CR72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cytogfr.2006.05.001","volume":"17","author":"V Budagian","year":"2006","unstructured":"Budagian V, Bulanova E, Paus R. Bulfone-Paus S. IL-15\/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17:259\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3777_CR73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.psyneuen.2010.07.017","volume":"36","author":"X Wu","year":"2011","unstructured":"Wu X, Hsuchou H, Kastin AJ, He Y, Khan RS, Stone KP, et al. Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15R\u03b1 receptor. Psychoneuroendocrinology. 2011;36:266\u201378.","journal-title":"Psychoneuroendocrinology"},{"key":"3777_CR74","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.1002373","volume":"186","author":"J-Q Yang","year":"2011","unstructured":"Yang J-Q, Wen X, Kim PJ, Singh RR. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner. J Immunol. 2011;186:1512\u201320.","journal-title":"J Immunol"},{"key":"3777_CR75","volume":"112","author":"M Zhao","year":"2019","unstructured":"Zhao M, Luo M, Xie Y, Jiang H, Cagliero C, Li N, et al. Development of a recombinant human IL-15\u00b7sIL-15R\u03b1\/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model. Biomed Pharmacother. 2019;112:108677.","journal-title":"Biomed Pharmacother"},{"key":"3777_CR76","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.0610115104","volume":"104","author":"N Sato","year":"2007","unstructured":"Sato N, Patel HJ, Waldmann TA, Tagaya Y. The IL-15\/IL-15R\u03b1 on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc Natl Acad Sci USA. 2007;104:588\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3777_CR77","doi-asserted-by":"crossref","first-page":"610789","DOI":"10.3389\/fimmu.2021.610789","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Zhao X-Y. Transcription factors associated with IL-15 cytokine signaling during NK cell development. Front Immunol. 2021;12:610789.","journal-title":"Front Immunol"},{"key":"3777_CR78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","volume":"23","author":"SP Leighton","year":"2018","unstructured":"Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23:48\u201358.","journal-title":"Mol Psychiatry"},{"key":"3777_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02757-2","volume":"20","author":"NV S\u00f8rensen","year":"2023","unstructured":"S\u00f8rensen NV, Borbye-Lorenzen N, Christensen RHB, Orlovska-Waast S, Jeppesen R, Skogstrand K, et al. Comparisons of 25 cerebrospinal fluid cytokines in a case\u2013control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects. J Neuroinflammation. 2023;20:90.","journal-title":"J Neuroinflammation"},{"key":"3777_CR80","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood.V90.7.2804","volume":"90","author":"R Badolato","year":"1997","unstructured":"Badolato R, Ponzi AN, Millesimo M, Notarangelo LD, Musso T. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood. 1997;90:2804\u20139.","journal-title":"Blood"},{"key":"3777_CR81","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","volume":"24","author":"AC Nugent","year":"2019","unstructured":"Nugent AC, Ballard ED, Gould TD, Park LT, Moaddel R, Brutsche NE, et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Mol Psychiatry. 2019;24:1040\u201352.","journal-title":"Mol Psychiatry"},{"key":"3777_CR82","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","volume":"42","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, et al. Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology. 2017;42:1210\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR83","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","volume":"28","author":"RE Daws","year":"2022","unstructured":"Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, et al. Increased global integration in the brain after psilocybin therapy for depression. Nat Med. 2022;28:844\u201351.","journal-title":"Nat Med"},{"key":"3777_CR84","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2018.01.027","volume":"84","author":"JW Evans","year":"2018","unstructured":"Evans JW, Szczepanik J, Brutsch\u00e9 N, Park LT, Nugent AC, Zarate CA. Default mode connectivity in major depressive disorder measured up to 10 dDays after ketamine administration. Biol Psychiatry. 2018;84:582\u201390.","journal-title":"Biol Psychiatry"},{"key":"3777_CR85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","volume":"26","author":"JJ Gattuso","year":"2023","unstructured":"Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, et al. Default mode network modulation by psychedelics: A systematic review. Int J Neuropsychopharmacol. 2023;26:155\u201388.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3777_CR86","volume":"42","author":"W Xu","year":"2023","unstructured":"Xu W, Patel CH, Zhao L, Sun I-H, Oh M-H, Sun I-M, et al. GOT1 regulates CD8+ effector and memory T cell generation. Cell Rep. 2023;42:111987.","journal-title":"Cell Rep"},{"key":"3777_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s42003-024-07381-1","volume":"8","author":"J Filoni","year":"2025","unstructured":"Filoni J, Ferrari A, Jofra T, Putignano AR, Da Dalt L, Cesarano S, et al. Metabolic reprogramming of na\u00efve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer. Commun Biol. 2025;8:99.","journal-title":"Commun Biol"},{"key":"3777_CR88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/dbio.1996.0255","volume":"179","author":"MD Michaelson","year":"1996","unstructured":"Michaelson MD, Mehler MF, Xu H, Gross RE, Kessler JA. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev Biol. 1996;179:251\u201363.","journal-title":"Dev Biol"},{"key":"3777_CR89","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neubiorev.2012.11.009","volume":"37","author":"W Pan","year":"2013","unstructured":"Pan W, Wu X, He Y, Hsuchou H, Huang EY-K, Mishra PK, et al. Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev. 2013;37:184\u201392.","journal-title":"Neurosci Biobehav Rev"},{"key":"3777_CR90","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1038\/s41380-025-03198-4","volume":"30","author":"M Li","year":"2025","unstructured":"Li M, Duan W, Hao X, Shuangjie Li S, Wang C, Liang Y, et al. Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms. Mol Psychiatry. 2025;30:6107\u201318.","journal-title":"Mol Psychiatry"},{"key":"3777_CR91","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106573","volume":"199","author":"L Chang","year":"2024","unstructured":"Chang L, Wei Y, Qu Y, Zhao M, Zhou X, Long Y, et al. Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis. Neurobiol Dis. 2024;199:106573.","journal-title":"Neurobiol Dis"},{"key":"3777_CR92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","volume":"49","author":"JN Johnston","year":"2024","unstructured":"Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology. 2024;49:23\u201340.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR93","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1073\/pnas.1816071116","volume":"116","author":"EW Lumsden","year":"2019","unstructured":"Lumsden EW, Troppoli TA, Myers SJ, Zanos P, Aracava Y, Kehr J, et al. Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function. Proc Natl Acad Sci USA. 2019;116:5160\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3777_CR94","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacol Rev. 2018;70:621\u201360.","journal-title":"Pharmacol Rev"},{"key":"3777_CR95","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70038","volume":"39","author":"M Adebo","year":"2025","unstructured":"Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, et al. Psilocybin as transformative fast\u2010acting antidepressant: Pharmacological properties and molecular mechanisms. Fundam Clin Pharmacol. 2025;39:e70038.","journal-title":"Fundam Clin Pharmacol"},{"key":"3777_CR96","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","volume":"118","author":"N Hesselgrave","year":"2021","unstructured":"Hesselgrave N, Troppoli TA, Wulff AB, Thompson SM. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc Natl Acad Sci. 2021;118:e2022489118.","journal-title":"Proc Natl Acad Sci"},{"key":"3777_CR97","doi-asserted-by":"crossref","first-page":"RP104006","DOI":"10.7554\/eLife.104006.3","volume":"14","author":"M Schmidt","year":"2026","unstructured":"Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, et al. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons. eLife. 2026;14:RP104006. Feb 17 [online ahead of print]","journal-title":"eLife"},{"key":"3777_CR98","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s43440-024-00660-y","volume":"76","author":"I Szpr\u0119giel","year":"2024","unstructured":"Szpr\u0119giel I, Bysiek A. Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases. Pharmacol Rep. 2024;76:1297\u2013304.","journal-title":"Pharmacol Rep"},{"key":"3777_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01411-w","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Su X, Li H, Li M, the 23andMe Research Team, Li W, et al. Transcriptome-wide association study identifies new susceptibility genes and pathways for depression. Transl Psychiatry. 2021;11:306.","journal-title":"Transl Psychiatry"},{"key":"3777_CR100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/YPG.0000000000000129","volume":"26","author":"L Zuo","year":"2016","unstructured":"Zuo L, Tan Y, Wang Z, Wang KS, Zhang X, Chen X, et al. Long noncoding RNAs in psychiatric disorders. Psychiatr Genet. 2016;26:109\u201316.","journal-title":"Psychiatr Genet"},{"key":"3777_CR101","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s42003-024-05779-5","volume":"7","author":"P Caldas","year":"2024","unstructured":"Caldas P, Luz M, Baseggio S, Andrade R, Sobral D, Grosso AR. Transcription readthrough is prevalent in healthy human tissues and associated with inherent genomic features. Commun Biol. 2024;7:100.","journal-title":"Commun Biol"},{"key":"3777_CR102","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09214","volume":"4","author":"AR Grosso","year":"2015","unstructured":"Grosso AR, Leite AP, Carvalho S, Matos MR, Martins FB, Vitor AC, et al. Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma. eLife. 2015;4:e09214.","journal-title":"eLife"},{"key":"3777_CR103","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-014-3019-2","volume":"146","author":"KE Varley","year":"2014","unstructured":"Varley KE, Gertz J, Roberts BS, Davis NS, Bowling KM, Kirby MK, et al. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat. 2014;146:287\u201397.","journal-title":"Breast Cancer Res Treat"},{"key":"3777_CR104","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41380-022-01905-z","volume":"28","author":"NV S\u00f8rensen","year":"2023","unstructured":"S\u00f8rensen NV, Frandsen BH, Orlovska-Waast S, Buus TB, \u00d8dum N, Christensen RH, et al. Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis. Mol Psychiatry. 2023;28:391\u2013401.","journal-title":"Mol Psychiatry"},{"key":"3777_CR105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.biopsych.2025.09.008","volume":"99","author":"C Erady","year":"2025","unstructured":"Erady C, Bethlehem R, Bullmore E, Lynall M-E. Systematic review and mega-analysis of the peripheral blood transcriptome in depression implicates dysregulation of lymphoid cells and histones. Biol Psychiatry. 2025;99:1130\u201340.","journal-title":"Biol Psychiatry"},{"key":"3777_CR106","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.20020033","volume":"195","author":"AW Goldrath","year":"2002","unstructured":"Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med. 2002;195:1515\u201322.","journal-title":"J Exp Med"},{"key":"3777_CR107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-016-0329-3","volume":"29","author":"HH Van Acker","year":"2016","unstructured":"Van Acker HH, Anguille S, Willemen Y, Van den Bergh JM, Berneman ZN, Lion E, et al. Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells. J Hematol Oncol. 2016;29:101.","journal-title":"J Hematol Oncol"},{"key":"3777_CR108","doi-asserted-by":"crossref","first-page":"e45299","DOI":"10.1371\/journal.pone.0045299","volume":"7","author":"TL Van Belle","year":"2012","unstructured":"Van Belle TL, Dooms H, Boonefaes T, Wei X-Q, Leclercq G, Grooten J. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells. PLoS One. 2012;7:e45299.","journal-title":"PLoS One"},{"key":"3777_CR109","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cyto.2017.08.004","volume":"99","author":"AT Waickman","year":"2017","unstructured":"Waickman AT, Ligons DL, Hwang S, Park J-Y, Lazarevic V, Sato N, et al. CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans. Cytokine. 2017;99:266\u201374.","journal-title":"Cytokine"},{"key":"3777_CR110","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41586-025-08880-9","volume":"641","author":"EN Chung","year":"2025","unstructured":"Chung EN, Lee J, Polonio CM, Choi J, Faust Akl C, Kilian M, et al. Psychedelic control of neuroimmune interactions governing fear. Nature. 2025;641:1276\u201386.","journal-title":"Nature"},{"key":"3777_CR111","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","volume":"45","author":"CA Farmer","year":"2020","unstructured":"Farmer CA, Gilbert JR, Moaddel R, George J, Adeojo L, Lovett J, et al. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology. 2020;45:1398\u2013404.","journal-title":"Neuropsychopharmacology"},{"key":"3777_CR112","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","volume":"27","author":"GC Medeiros","year":"2022","unstructured":"Medeiros GC, Gould TD, Prueitt WL, Nanavati J, Grunebaum MF, Farber NB, et al. Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis. Mol Psychiatry. 2022;27:3658\u201369.","journal-title":"Mol Psychiatry"},{"key":"3777_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"J-M Oh","year":"2020","unstructured":"Oh J-M, Venters CC, Di C, Pinto AM, Wan L, Younis I, et al. U1 snRNP regulates cancer cell migration and invasion in vitro. Nat Commun. 2020;11:1.","journal-title":"Nat Commun"},{"key":"3777_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, et al. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021;12:5692.","journal-title":"Nat Commun"},{"key":"3777_CR115","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1038\/s41380-022-01668-7","volume":"27","author":"M Engeln","year":"2022","unstructured":"Engeln M, Fox ME, Chandra R, Choi EY, Nam H, Qadir H, et al. Transcriptome profiling of the ventral pallidum reveals a role for pallido-thalamic neurons in cocaine reward. Mol Psychiatry. 2022;27:3980\u201391.","journal-title":"Mol Psychiatry"},{"key":"3777_CR116","doi-asserted-by":"crossref","first-page":"bbab356","DOI":"10.1093\/bib\/bbab356","volume":"23","author":"F Xia","year":"2022","unstructured":"Xia F, Allen J, Balaprakash P, Brettin T, Garcia-Cardona C, Clyde A, et al. A cross-study analysis of drug response prediction in cancer cell lines. Brief Bioinform. 2022;23:bbab356.","journal-title":"Brief Bioinform"},{"key":"3777_CR117","doi-asserted-by":"crossref","first-page":"jkad143","DOI":"10.1093\/g3journal\/jkad143","volume":"13","author":"A Vannan","year":"2023","unstructured":"Vannan A, Dell\u2019Orco M, Perrone-Bizzozero NI, Neisewander JL, Wilson MA. An approach for prioritizing candidate genes from RNA-seq using preclinical cocaine self-administration datasets as a test case. G3 (Bethesda). 2023;13:jkad143.","journal-title":"G3 (Bethesda)"},{"key":"3777_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00535-z","volume":"162","author":"J Wang","year":"2025","unstructured":"Wang J, Song G, Xing L. Multi-Omics analysis and in vitro validation reveal diagnostic and therapeutic roles of novel hub genes in ovarian cancer. Hereditas. 2025;162:166.","journal-title":"Hereditas"},{"key":"3777_CR119","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/ph18091298","volume":"18","author":"GN Silva","year":"2025","unstructured":"Silva GN, Brand\u00e3o VGA, Blum K, Lewandrowski K-U, Fiorelli RKA. Ketamine\u2019s role in neuroinflammation and neuroprotection across neurological and psychiatric disorders: A narrative review. Pharmaceuticals (Basel). 2025;18:1298.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3777_CR120","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/molecules29215084","volume":"29","author":"KR Wiens","year":"2024","unstructured":"Wiens KR, Brooks NAH, Riar I, Greuel BK, Lindhout IA, Klegeris A. Psilocin, the psychoactive metabolite of psilocybin, modulates select neuroimmune functions of microglial cells in a 5-HT2 receptor-dependent manner. Molecules. 2024;29:5084.","journal-title":"Molecules"},{"key":"3777_CR121","doi-asserted-by":"crossref","unstructured":"Jones G, Machado-Vieira R The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller \u201cBurning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies\u201d. Mol Psychiatry 2023; 28: 3164-6.","DOI":"10.1038\/s41380-023-02102-2"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03777-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:07:07Z","timestamp":1793833627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":121,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03777-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Zarate is listed as a co-inventor on a patent for the use of ketamine in major depression and suicidal ideation; Dr. Zarate and Dr. Moaddel are listed as co-inventors on a patent for the use of (2\u2009\n                      R\n                      ,6\u2009\n                      R\n                      )-hydroxynorketamine, (\n                      S\n                      )-dehydronorketamine, and other stereoisomeric dehydroxylated and hydroxylated metabolites of (\n                      R,S\n                      )-ketamine in the treatment of depression and neuropathic pain; and as co-inventors on a patent application for the use of (2\u2009\n                      R\n                      ,6\u2009\n                      R\n                      )-hydroxynorketamine and (2\n                      S\n                      ,6\n                      S\n                      )-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, suicidal ideation, and post-traumatic stress disorder. They have assigned their patent rights to the U.S. government but will share a percentage of any royalties that may be received by the government. Dr. Machado-Vieira has received consulting fees from Eurofarma Pharmaceuticals, Abbott, and the BioStrategies Group, and has a research contract for trials with Janssen and Boehringer-Ingelheim Pharmaceuticals. Dr. Machado-Vieira has also received speaker fees from Otsuka, Lundbeck, EMS, and Cristalia, and is a member of the scientific board of Symbinas Pharmaceuticals and Allergan. Dr. Kvarta holds and receives royalties from a patent for the use of negative modulators of GABA receptors containing \u03b15 subunits as rapid-acting antidepressants, with rights assigned to the University of Maryland, Baltimore. Dr. Kadriu is presently employed full-time and holds shares in Bristol Myers Squibb. He was previously employed by Johnson & Johnson and Jazz Pharmaceuticals, where he maintains share ownership. All other authors have no conflict of interest to disclose, financial or otherwise.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Institutional Review Board of the National Institutes of Health under protocol numbers 01-M-0254 and 15-M-0151 (iPSC-based studies) and 04-M-0222 (ketamine clinical trial and associated biomarker data. All methods were performed in accordance with the relevant guidelines and regulations, and all participants provided written informed consent.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}